Form 4 for IRMD IRADIMED CORP
Accepted 2021-11-24 00:00:00 ET · period of report 2021-11-23 · accession 0000898432-21-000738 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-24 | 2021-11-23 | IRMD | Scott Christopher K. | COO, CFO, Sec | S - Sale | $40.98 | -26.7K | 28.6K | -48% | -$1.09M |
| D | 2021-11-24 | 2021-11-23 | IRMD | Scott Christopher K. | COO, CFO, Sec | A - Grant | $9.84 | +26.7K | 55.3K | +93% | +$262.9K |
| D | 2021-11-24 | 2021-11-23 | IRMD | Scott Christopher K. | COO, CFO, Sec | M - OptEx | $0.00 | -26.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-23 | S | D | 26,715 | $40.98 | 28,595 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $40.58 to $41.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected. |
| 2 | Common | Common Stock | 2021-11-23 | A | A | 26,715 | $9.84 | 55,310 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2021-11-23 | M | D | 26,715 | $0.00 | 0 | D | $9.84 · — to 2024-12-15 | 26,715 Common Stock | (F2) This option was granted on 12-15-2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. |